Daftar Isi
1. Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolio
2. Teva Pharmaceuticals CEO talks Trump and US healthcare
Pharmaceutical companies brace for the upcoming Trump administration.
3. Teva Pharmaceuticals CEO on earnings beat: Our shift to biopharma is working
Richard Francis,
4. Teva Pharmaceuticals reaches $4.3B deal in nationwide opioid settlement
The money will be disbursed to states, local governments and Native American tribes involved in negotiations.
5. FDA warns of Adderall shortage after Teva manufacturing delay
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's warning of an Adderall shortage after
6. 480 million doses of medicine: Go behind the Scenes at Teva's UK plant
Join Hikky, Paul and Amy as they take us behind the scenes and show us some of the quality and safety checks that goes in to ...
7. FDA approves Teva's generic EpiPen
CNBC's Meg Tirrell reports on U.S. regulators clearing the first generic competitor to Mylan's EpiPen, after a yearslong delay that ...
8. Teva Time Capsule - Our History
We've come a long way from one pharmacy in 1901. For over 120 years,
9. TEVA - Delivering Cures and Hopes Around the Globe
10. Teva in Talks to Help Make Covid Vaccines, CEO Says
Feb.10 --
11. Teva Pharmaceuticals Facts and Figures
We are all in for better health.
12. Teva's CEO talks Q4 earnings and how he is implementing his 'pivot to growth' strategy
Shares of
13. Teva Corporate Video (2021)
There are many things that we can count: our tens of thousands of employees, the number of countries in which we operate, the ...
14. Teva Time Capsule - Our History (short)
15. KOMU: Teva stonewalling McCaskill opioids investigation
Informasi selengkapnya mengenai KOMU: Teva stonewalling McCaskill opioids investigation. Silakan unduh atau baca konten berikut.
Teva 3325 Information Guide
Introduction to Teva 3325
Important Facts
Developments
Deep Dive
Data is compiled from public records and verified media reports.
Last Updated: August 10, 2026
Summary
Disclaimer: Disclaimer: All information is compiled from publicly available data, media reports, and analysis. Actual details may vary.